Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_assertion type Assertion NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_head.
- NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_assertion description "[TMPRSS2-ERG, TMPRSS2-ETV1, and SLC45A3-ERG rearrangements account for roughly 90% of ETS fusion prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_provenance.
- NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_assertion evidence source_evidence_literature NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_provenance.
- NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_assertion SIO_000772 19293179 NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_provenance.
- NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_assertion wasDerivedFrom befree-20140225 NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_provenance.
- NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_assertion wasGeneratedBy ECO_0000203 NP378862.RAR54kYrn4k-KJHrLzA3Rlycn9VgS4IlEi2KkQDzoX93I130_provenance.